Medico Remedies Ltd - 540937 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- HARESH MEHTADesignation :- Managing Director / Whole Time Director Medico Remedies Ltd - 540937 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 02, 2021 for Rishit Hareshbhai Mehta Medico Remedies Ltd - 540937 - Financial Results For The Half Year Ended On 31St March 2021
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors at their Meeting held today i.e. 27th May, 2021 has, inter alia considered and approved the following: 1. Audited Financial Results for the half year ended 31st March, 2021 and Audited Financial Statements for the year ended on 31st March, 2021. 2. Revision in terms of remuneration of Mr. Haresh Mehta, Chairman and Whole Time Director of the Company. 3. Revision in terms of remuneration of Mr. Harshit Mehta, Managing Director of the Company 4. Revision in terms of remuneration of Mr. Rishit Mehta, Whole Time Director of the Company We wish to inform you that the Board Meeting commenced today at 2.30 P.M and concluded at 3:50 P.M Kindly take the same on record and oblige. Medico Remedies Ltd - 540937 - Outcome
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors at their Meeting held today i.e. 27th May, 2021 has, inter alia considered and approved the following: 1. Audited Financial Results for the half year ended 31st March, 2021 and Audited Financial Statements for the year ended on 31st March, 2021. 2. Revision in terms of remuneration of Mr. Haresh Mehta, Chairman and Whole Time Director of the Company. 3. Revision in terms of remuneration of Mr. Harshit Mehta, Managing Director of the Company 4. Revision in terms of remuneration of Mr. Rishit Mehta, Whole Time Director of the Company We wish to inform you that the Board Meeting commenced today at 2.30 P.M and concluded at 3:50 P.M Kindly take the same on record and oblige Medico Remedies Ltd - 540937 - Board Meeting Intimation for Audited Financial Results For The Half Year Ended 31St March, 2021 And Audited Financial Statements For The Year Ended On 31St March, 2021
Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2021 ,inter alia, to consider and approve 1. Audited Financial Results for the half year ended 31st March, 2021 and Audited Financial Statements for the year ended on 31st March, 2021 2. Any other business with the permission of the Chair Medico Remedies Ltd - 540937 - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31St March, 2021
Certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended 31st March, 2021 Medico Remedies Ltd - 540937 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rishit Hareshbhai Mehta Medico Remedies Ltd - 540937 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rishit Hareshbhai Mehta Medico Remedies Ltd - 540937 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 21, 2021 for Rishit Hareshbhai Mehta Medico Remedies Ltd - 540937 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 21, 2021 for Rishit Hareshbhai Mehta